Literature DB >> 19410620

Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.

J Gethmann1, K Hüttner, H Heyne, C Probst, M Ziller, M Beer, B Hoffmann, T C Mettenleiter, F J Conraths.   

Abstract

After massive epidemics of bluetongue disease in 2006 and 2007, Germany has started a compulsory vaccination program against bluetongue virus serotype 8 (BTV-8). Since the available vaccines had not yet been registered and only limited data were available on their performance, a safety study was conducted with three different inactivated monovalent vaccines under consideration for use in Germany. A total of 1007 sheep and 893 cattle were vaccinated and subsequently compared with 638 control animals (324 sheep and 314 cattle). During the study, all animals remained in good health condition. After the initial immunisation, only local swellings were observed in a small number of animals. Following revaccination, several sheep developed more distinct local reactions and a temporary rise in body temperature. Severe systemic reactions were not detected in any of the study groups. Among cattle, neither fever, nor a decrease in milk production and only temporary low-grade local reactions were observed. Overall, our results demonstrate a high level of safety of all vaccines tested.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19410620     DOI: 10.1016/j.vaccine.2009.04.072

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Three years of bluetongue disease in central Europe with special reference to Germany: what lessons can be learned?

Authors:  Helge Kampen; Doreen Werner
Journal:  Wien Klin Wochenschr       Date:  2010-10       Impact factor: 1.704

2.  Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.

Authors:  Jenna Anderson; Sara Hägglund; Emmanuel Bréard; Loic Comtet; Karin Lövgren Bengtsson; John Pringle; Stéphan Zientara; Jean Francois Valarcher
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

3.  Characterization of the immune response induced by a commercially available inactivated bluetongue virus serotype 1 vaccine in sheep.

Authors:  Ana Cristina Pérez de Diego; Pedro José Sánchez-Cordón; Ana Isabel de las Heras; José Manuel Sánchez-Vizcaíno
Journal:  ScientificWorldJournal       Date:  2012-04-24

4.  Financial evaluation of different vaccination strategies for controlling the bluetongue virus serotype 8 epidemic in The Netherlands in 2008.

Authors:  Annet G J Velthuis; Monique C M Mourits; Helmut W Saatkamp; Aline A de Koeijer; Armin R W Elbers
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

5.  Evaluation of the humoral immune responses in adult cattle and sheep, 4 and 2.5 years post-vaccination with a bluetongue serotype 8 inactivated vaccine.

Authors:  C A Batten; L Edwards; C A L Oura
Journal:  Vaccine       Date:  2013-06-19       Impact factor: 3.641

6.  Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.

Authors:  Johanna Hilke; Heinz Strobel; Soeren Woelke; Melanie Stoeter; Katja Voigt; Bernd Moeller; Max Bastian; Martin Ganter
Journal:  Viruses       Date:  2019-06-08       Impact factor: 5.048

7.  Improved safety profile of inactivated Neethling strain of the Lumpy Skin Disease Vaccine.

Authors:  Matome Selina Matsiela; Leeann Naicker; Vusi Saul Dibakwane; Nomfundo Ntombela; Thandeka Khoza; Nobalanda Mokoena
Journal:  Vaccine X       Date:  2022-08-18

8.  Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.

Authors:  Tamara Kusay Jabbar; Eva Calvo-Pinilla; Francisco Mateos; Simon Gubbins; Abdelghani Bin-Tarif; Katarzyna Bachanek-Bankowska; Oya Alpar; Javier Ortego; Haru-Hisa Takamatsu; Peter Paul Clement Mertens; Javier Castillo-Olivares
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

9.  Did vaccination slow the spread of bluetongue in France?

Authors:  Maryline Pioz; Hélène Guis; David Pleydell; Emilie Gay; Didier Calavas; Benoît Durand; Christian Ducrot; Renaud Lancelot
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Magnetic resonance imaging to detect local tissue reactions after vaccination in sheep in vivo.

Authors:  Maren Bernau; Prisca Valerie Kremer-Rücker; Lena Sophie Kreuzer; Sebastian Schwanitz; Klaus Cussler; Andreas Hoffmann; Armin Manfred Scholz
Journal:  Vet Rec Open       Date:  2017-09-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.